Author:
Moo-Puc Rosa E.,Villanueva-Toledo Jairo,Arankowsky-Sandoval Gloria,Alvarez-Cervera Fernando,Góngora-Alfaro José L.
Reference16 articles.
1. Anticholinergic drugs used in Parkinson’s disease: an overlooked class of drugs from a pharmacokinetic perspective;Brocks;J. Pharm. Pharmaceut. Sci.,1999
2. Clinically significant pharmacokinetic interactions between dietary caffeine and medications;Carrillo;Clin. Pharmacokinet.,2000
3. Reserpine-insensitive dopamine release in the substantia nigra?;Elvefors;Brain Res.,1991
4. Medical treatment of Parkinson’s disease;Fahn;J. Neurol.,1998
5. S. Fahn, R. Burke, Y. Stern, Antimuscarinic drugs in the treatment of movement disorders, in: S.-M. Aquilonius, P.-G. Gillberg (Eds.), Progress in Brain Research, vol. 84, Elsevier, Amsterdam, 1990, pp. 389–397.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献